跳至主要内容
临床试验/NCT01263561
NCT01263561已完成不适用

Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy

University of Toronto2 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
2
主要终点
Intraocular Pressure

研究概览

简要总结

Prospective randomized study comparing guarded Ex-PRESS to trabeculectomy. Primary outcome: IOP and success (complete success defined as IOP between 5-18 mmHg and 20% reduction from baseline without medication or additional glaucoma surgery and qualified success defined as IOP between 5-18 mmHg and 20% reduction from baseline with or without glaucoma medication but no additional glaucoma surgery). Secondary outcomes: number of glaucoma medications, visual acuity, number of complications, corneal pachymetry and corneal endothelial cell counts.

详细描述

Complications will be evaluated for the intra-operative, early post-operative (up until 1 month) and late post-operative (from 1 month to 1 year) periods. In addition complications will be evaluated as severe (defined as a permanent reduction in vision or complications requiring a surgical intervention) and not severe (complications which resolve with conservative management). As an individual subject may have more than one complication, the number of complications will be compared between the two surgical groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 to 85
  • open-angle glaucoma uncontrolled medically
  • intraocular pressure ≥ 18 mmHg
  • trabeculectomy as the planned surgical procedure

排除标准

  • any previous ocular incisional surgery with the exception of previous clear
  • cornea cataract surgery
  • vitreous present in anterior chamber
  • patient unwilling or unable to accept randomization or to give consent or to attend the follow up visits

结局指标

主要结局

Intraocular Pressure

时间窗: 1 year post surgery

Success Rate (IOP Between 5-18 mmHg and 20% Reduction From Baseline) Without Glaucoma Medication

时间窗: 1 year post surgery

次要结局

  • Complications(1 year post surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yvonne Buys

MD, FRCSC; Professor

University of Toronto

研究点 (2)

Loading locations...

相似试验